RecruitingEarly Phase 1NCT06392854

Regional Lipolysis Insulin Regulation

Insulin Regulation of Regional Lipolysis


Sponsor

Mayo Clinic

Enrollment

48 participants

Start Date

May 1, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

Adults who gain most of their excess weight in the abdominal area typically do not respond to insulin in the same way as lean adults. Researchers are trying to understand why fat tissue responds differently in people with different body types.


Eligibility

Min Age: 18 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Insulin for people with obesity. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 65 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGInsulin

2 dose insulin infusion 4 hours


Locations(1)

Mayo Clinic in Rochester

Rochester, Minnesota, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06392854


Related Trials